Leuprolide Acetate 45mg Depot Injection

Leuprolide Acetate 45mg is a long-acting gonadotropin-releasing-hormone agonist used in advanced prostate cancer. The 45mg depot provides sustained hormone suppression over a six-month treatment interval.
The two-syringe depot system is mixed and administered under the skin by a trained professional. This six-month formulation is not given into a vein or substituted using the schedule of a monthly depot.
After an initial stimulation phase, continuous GnRH-receptor activation suppresses pituitary LH release and lowers testosterone production.
Hot flushes, injection-site discomfort, fatigue, reduced sexual function and weight changes can occur. Bone loss and changes in glucose or cardiovascular risk are important with prolonged treatment.
Testosterone can rise temporarily at the start. Existing spinal metastases or urinary obstruction require particular attention during this initial flare period.
Maintains prolonged testosterone suppression to help control androgen-dependent cancer activity.
The initial testosterone rise can cause a tumour flare before suppression develops. An additional antiandrogen may be used during that period.
No. Monthly, three-monthly and six-monthly formulations have different strengths and release characteristics.
Testosterone testing confirms that the depot is maintaining the intended hormone suppression.
Sustained testosterone reduction can reduce bone density and increase fracture risk.
Depot: a formulation that releases medicine over an extended period. GnRH agonist: a medicine that ultimately suppresses sex-hormone production. Tumour flare: temporary worsening associated with an initial hormone rise.; AR: Leuprolide Acetate 45mg حقن; FR: Leuprolide Acetate 45mg injection; PT: Leuprolide Acetate 45mg injeção; ES: Leuprolide Acetate 45mg inyección; RU: Leuprolide Acetate 45mg инъекция; ID: Leuprolide Acetate 45mg suntikan; VI: Leuprolide Acetate 45mg thuốc tiêm; MS: Leuprolide Acetate 45mg suntikan; TL: Leuprolide Acetate 45mg iniksyon; ZH-SG: Leuprolide Acetate 45mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Leuprolide Acetate 45mg Depot Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Leuprolide Acetate 45mg Depot Injection